Evidence map›Paper›PMID 31134360›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2019

In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De-ESCALaTE.

Petar Suton, Marko Skelin, Zoran Rakusic, Stjepan Dokuzovic, Ivica Luksic

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Petar SutonDepartment of Radiotherapy and Medical Oncology, University Hospital Centre "Sisters of Mercy", University Hospital for Tumors, Ilica 197, 10000, Zagreb, Croatia. petarsuton@yahoo.com.ORCID 0000-0001-7779-3174
Marko SkelinPharmacy Department, General Hospital Sibenik, Stjepana Radica 83, Sibenik, Croatia.
Zoran RakusicDepartment of Oncology, University Hospital Centre Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia.
Stjepan DokuzovicDepartment of Traumatology and Orthopaedics, University Hospital Dubrava, Avenue Gojko Susak 6, 10000, Zagreb, Croatia.
Ivica LuksicDepartment of Maxillofacial Surgery, University Hospital Dubrava, University of Zagreb School of Medicine, Avenue Gojko Susak 6, 10000, Zagreb, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CisplatinOropharyngeal NeoplasmsCetuximabChemoradiotherapyHumansCetuximabCisplatin

Identifiers

PMID31134360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.